Balyasny Asset Management LLC Agios Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$27.55 - $48.83 $1.01 Million - $1.79 Million	-36,695 Reduced 46.75%	41,793 $1.8 Million
Q1 2024 May 13, 2024	BUY	$21.32 - $34.81 $777,860 - $1.27 Million	36,485 Added 86.86%	78,488 $2.29 Million
Q4 2023 Feb 14, 2024	SELL	$19.97 - $24.53 $4.45 Million - $5.47 Million	-223,034 Reduced 84.15%	42,003 $935,000
Q3 2023 Nov 14, 2023	BUY	$24.36 - $28.18 $1.14 Million - $1.32 Million	46,937 Added 21.52%	265,037 $6.56 Million
Q2 2023 Aug 14, 2023	SELL	$21.38 - $29.19 $2.2 Million - $3 Million	-102,907 Reduced 32.06%	218,100 $6.18 Million
Q1 2023 May 15, 2023	BUY	$21.74 - $30.93 $901,122 - $1.28 Million	41,450 Added 14.83%	321,007 $7.37 Million
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $6.94 Million - $8.81 Million	279,557 New	279,557 $7.85 Million
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $2.99 Million - $4.19 Million	-89,988 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $3.05 Million - $5.03 Million	89,988 New	89,988 $3.15 Million
Q2 2019 Aug 14, 2019	SELL	$46.17 - $68.1 $197,284 - $290,991	-4,273 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $3.72 Million - $5.48 Million	-81,003 Reduced 94.99%	4,273 $288,000
Q4 2018 Feb 14, 2019	SELL	$42.73 - $76.53 $11.4 Million - $20.4 Million	-266,721 Reduced 75.77%	85,276 $3.93 Million
Q3 2018 Nov 14, 2018	SELL	$71.67 - $91.95 $3.94 Million - $5.05 Million	-54,955 Reduced 13.5%	351,997 $27.1 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $20.2 Million - $27.5 Million	-276,412 Reduced 40.45%	406,952 $34.3 Million
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $26.7 Million - $38.7 Million	-446,899 Reduced 39.54%	683,364 $55.9 Million
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $8.55 Million - $11.9 Million	164,111 Added 16.99%	1,130,263 $64.6 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $53 Million - $64.8 Million	966,152	966,152 $64.5 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$195 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$191 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$167 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$129 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$97.5 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account